SPG11 and Brain atrophy: All these SPG11 studies, with concomitant spatacsin mutations involved in axonal stability and transport (12), presented additional findings such as TCC, WM hyperintensities, brain atrophy, and impaired DTI indexes in areas related to CST tracts.